URGENT: The M&A Class Action Firm Encourages $hareholders to Act Before Vote – Titan Pharmaceuticals, Inc. (Nasdaq: TTNP)
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jul 29 2025
0mins
Source: Globenewswire
Class Action Firm Recognition: Monteverde & Associates PC, led by attorney Juan Monteverde, is recognized as a Top 50 Firm for recovering millions for shareholders and is currently investigating Titan Pharmaceuticals' proposed merger with BSKE Ltd.
Shareholder Vote Information: Titan Pharmaceuticals shareholders are encouraged to participate in the upcoming vote on August 26, 2025, regarding the merger, with no cost or obligation for those seeking more information.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
